Sage Journals: Discover world-class research

Abstract

Major advances in cardiovascular intervention for chronic disease are underway. These innovations lie at the interface of minimally invasive catheter-based technologies and biologic approaches for the management of complex cardiovasculardiseases. This review highlights key areas where such ‘biointerventional’ cardiovascular therapies are envisioned to occur: cardiac cell transplantation, myocardial gene therapy, genetic and photodynamic endovascular interventions, and vascular tissue engineering.

Keywords

bioengineering cardiomyopathy cardiomyoplasty congestive heart failure gene percutaneous tissue engineering

References

Napheys G (ed). The prevention and cure of disease. In: Diseases of the heart. Chicago, IL; Springfield, MA: WJ Holland & Co, 1871: 935-944.

Oesterle SN , Reifart N , Hauptmann E , Hayase M , Yeung AC. Percutaneous in situ coronary venous arterialization: report of the first human catheter-based coronary artery bypass. Circulation 2001; 103: 2539-2543.

Oesterle S , Yeung A , Lo S et al. Percutaneous in-situ coronary venous arterialization (PICVA) improves survival in response to acute ischemia in the porcine model. J Am Coll Cardiol 2000; 35 (2 suppl): 61A-61A.

Oesterle SN , Sanborn TA , Ali N et al. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet 2000; 356: 1705-1710.

Yeung A , Hayase M , Fitzgerald P et al. Percutaneous in situ coronary artery bypass (PICAB): current development status and preliminary results of a novel myocardial revascularization technique. J Am Coll Cardiol 1999; 33 (2 suppl): 47A-47A.

Koh GY , Klug MG , Soonpaa MH , Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 1993; 92(3): 1548-1554.

Soonpaa MH , Koh GY , Klug MG , Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994; 264: 98-101.

Koh GY , Soonpaa MH , Klug MG et al. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 1995; 96(4): 2034-2042.

Leor J , Patterson M , Quinones MJ , Kedes LH , Kloner RA. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation 1996; 94 (9 suppl): II-332-II-336.

10.

Scorsin M , Marotte F , Sabri A et al. Can grafted cardiomyocytes colonize peri-infarct myocardial areas? Circulation 1996; 94 (9 suppl): II-337-II-340.

11.

Reinecke H , Zhang M , Bartosek T , Murry CE. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 1999; 100: 193-202.

12.

Matsushita T , Oyamada M , Kurata H et al. Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction. Circulation 1999; 100 (19 suppl): II-262-II-268.

13.

Li RK , Jia ZQ , Weisel RD et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996; 62: 654-660; discussion 660-61.

14.

Li RK , Mickle DA , Weisel RD , Zhang J , Mohabeer MK. In vivo survival and function of transplanted rat cardiomyocytes. Circ Res 1996; 78: 283-288.

15.

Scorsin M , Hagege AA , Marotte F et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation 1997; 96 (9 suppl): II-188-II-193.

16.

Gojo S , Kitamura S , Germeraad WT , Yoshida Y , Niwaya K , Kawachi K. Ex vivo gene transfer into myocardium using replication-defective retrovirus. Cell Transplant 1996; 5 (5 suppl 1): S81-S84.

17.

Li RK , Mickle DA , Weisel RD et al. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 1997; 96 (9 suppl): II-179-II-186; discussion 186-87.

18.

Yoo KJ , Li RK , Weisel RD , Mickle DA , Li G , Yau TM. Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg 2000; 70: 859-865.

19.

Sakai T , Li RK , Weisel RD et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg 1999; 118: 715-724.

20.

Taylor DA , Silvestry SC , Bishop SP et al. Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair. Proc Assoc Am Physicians 1997; 109: 245-253.

21.

Taylor DA , Atkins BZ , Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998; 4: 929-933.

22.

Atkins BZ , Hueman MT , Meuchel J , Hutcheson KA , Glower DD , Taylor DA. Cellular cardiomyoplasty improves diastolic properties of injured heart. J Surg Res 1999; 85: 234-242.

23.

Atkins BZ , Hueman MT , Meuchel JM , Cottman MJ , Hutcheson KA , Taylor DA. Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. J Heart Lung Transplant 1999; 18: 1173-1180.

24.

Atkins BZ , Lewis CW , Kraus WE , Hutcheson KA , Glower DD , Taylor DA. Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ. Ann Thorac Surg 1999; 67: 124-129.

25.

Scorsin M , Hagege A , Vilquin JT et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 2000; 119: 1169-1175.

26.

Pittenger MF , Mackay AM , Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.

27.

Makino S , Fukuda K , Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103: 697-705.

28.

Wang JS , Shum-Tim D , Galipeau J , Chedrawy E , Eliopoulos N , Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 2000; 120: 999-1005.

29.

Tomita S , Li RK , Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100(19 suppl): II-247-II-256.

30.

Orlic D , Kajstura J , Chimenti S , Bodine DM , Leri A , Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001; 938: 221-229; discussion 229-30.

31.

Kocher AA , Schuster MD , Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-436.

32.

Menasche P , Hagege A , Scorsin M et al [Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case.] Arch Mal Coeur Vaiss 2001; 94: 180-182.

33.

Krokan H , Prydz H. Gene transfer - ways of administration, advantages, possible unsuitability and hazards. Tidsskr Nor Laegeforen 2001; 121: 479-482.

34.

Loisel S , Le Gall C , Doucet L , Ferec C , Floch V. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther 2001; 12: 685-696.

35.

Wu J , Lizarzaburu ME , Kurth MJ et al. Cationic lipid polymerization as a novel approach for constructing new DNA delivery agents. Bioconjug Chem 2001; 12: 251-257.

36.

Saravolac EG , LudkovskiO , Skirrow R et al. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. J Drug Target 2000; 7: 423-437.

37.

Brazeau GA , Attia S , Poxon S , Hughes JA. In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery. Pharm Res 1998; 15: 680-684.

38.

Yla-Herttuala S , Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-222.

39.

Khurana R , Martin JF , Zachary I. Gene therapy for cardiovascular disease. A case for cautious optimism. Hypertension 2001; 38: 1210-1216.

40.

Barr E , Carroll J , Kalynych AM et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1994; 1: 51-58.

41.

Boekstegers P , von Degenfeld G , Giehrl W et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther 2000; 7: 232-240.

42.

Li JJ , Ueno H , Pan Y et al. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc Res 1995; 30: 97-105.

43.

Vale PR , Losordo DW , Tkebuchava T , Chen D , Milliken CE , Isner JM. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol 1999; 34: 246-254.

44.

Kornowski R , Leon MB , Fuchs S et al. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. J Am Coll Cardiol 2000; 35: 1031-1039.

45.

Sanborn TA , Hackett NR , Lee LY et al. Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Catheter Cardiovasc Interv 2001; 52: 260-266.

46.

Vale PR , Losordo DW , Milliken CE et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001; 103: 2138-2143.

47.

Shah AS , Lilly RE , Kypson AP et al. Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart: prospects for molecular ventricular assistance. Circulation 2000; 101: 408-414.

48.

Weig HJ , Laugwitz KL , Moretti A et al. Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors in vivo by ultrasound-guided injection or transcoronary delivery. Circulation 2000; 101: 1578-1585.

49.

Miyamoto MI , del Monte F , Schmidt U et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 2000; 97: 793-798.

50.

Hajjar RJ , Schmidt U , Matsui T et al. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 1998; 95: 5251-5256.

51.

Harada M , Toki Y , Numaguchi Y et al. Prostacyclin synthase gene transfer inhibits neointimal formation in rat balloon-injured arteries without bleeding complications. Cardiovasc Res 1999; 43: 481-491.

52.

Simons M , Edelman ER , DeKeyser JL , Langer R , Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992; 359: 67-70.

53.

Simons M , Rosenberg RD. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 1992; 70: 835-843.

54.

Shi Y , Fard A , Galeo A et al. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation 1994; 90: 944-951.

55.

Simons M , Edelman ER , Rosenberg RD. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J Clin Invest 1994; 93: 2351-2356.

56.

Morishita R , Gibbons GH , Ellison KE et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 1993; 90: 8474-8478.

57.

Mann MJ , Whittemore AD , Donaldson MC et al. Ex vivo gene therapy of human vascular bypass grafts with E2F decoy, the PREVENT single centre, randomised controlled trial. Lancet 1999; 354: 1493-1498.

58.

Von der Leyen HE , Gibbons GH , Morishita R et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137-1141.

59.

Rockson SG , Kramer P , Razavi M et al. Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin). Circulation 2000; 102: 2322-2324.

60.

Rockson SG , Lorenz DP , Cheong WF , Woodburn KW. Photoangioplasty: an emerging clinical cardiovascular role for photodynamic therapy. Circulation 2000; 102: 591-596.

61.

Yamaguchi A , Woodburn KW , Hayase M , Robbins RC. Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model. Circulation 2000; 102 (19 suppl 3): III-275-III-280.

62.

Yamaguchi A , Woodburn KW , Hayase M , Hoyt G , Robbins RC. Photodynamic therapy with motexafin lutetium (Lu-Tex) reduces experimental graft coronary artery disease. Transplantation 2001; 71: 1526-1532.

63.

Hayase M , Woodbum KW , Perlroth J et al. Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model. Cardiovasc Res 2001; 49: 449-455.

64.

Chen Z , Woodburn KW , Shi C , Adelman DC , Rogers C , Simon DI. Photodynamic therapy with motexafin lutetium induces redox-sensitive apoptosis of vascular cells. Arterioscler Thromb Vasc Biol 2001; 21: 759-764.

65.

Vacanti J , Langer R. Tissue engineering: the design and fabrication of living replacement tissues for surgical reconstruction and transplantation. Lancet 1999; 354 (supp I): 32-34.

66.

Weinberg C , Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231: 397-400.

67.

L’Heureux N , Paquet S , Labbe R , Germain L , Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998; 12: 47-56.

68.

Niklason LE , Gao J , Abbott WM et al. Functional arteries grown in vitro. Science 1999; 284: 489-493.

69.

Campbell JH , Efendy JL , Campbell GR. Novel vascular graft grown within recipient’s own peritoneal cavity. Circ Res 1999; 85: 1173-1178.

Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering

Abstract

Keywords

References